Virogenbio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Virogenbio General Information

Description

Developer of therapeutics designed to reset the immune system. The company's technology clears pathogenic T-cell states and allows for immune reconstitution, providing patients with immune-related diseases with a method for durable disease resolution.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 202, 2nd Floor, Building 11
  • Number 88, Keyuan South Road, High-tech Zone
  • Chengdu, Sichuan 610000
  • China
+86 028
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 202, 2nd Floor, Building 11
  • Number 88, Keyuan South Road, High-tech Zone
  • Chengdu, Sichuan 610000
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Virogenbio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 09-Sep-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 19-Jun-2024 Completed Generating Revenue
1. Seed Round 19-Aug-2022 Completed Startup
To view Virogenbio’s complete valuation and funding history, request access »

Virogenbio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Espressif Corporation Minority
Shenzhen Jinhengfu Private Equity Investment Fund Management Venture Capital Minority
To view Virogenbio’s complete investors history, request access »

Virogenbio FAQs

  • When was Virogenbio founded?

    Virogenbio was founded in 2022.

  • Where is Virogenbio headquartered?

    Virogenbio is headquartered in Chengdu, China.

  • What industry is Virogenbio in?

    Virogenbio’s primary industry is Drug Discovery.

  • Is Virogenbio a private or public company?

    Virogenbio is a Private company.

  • What is Virogenbio’s current revenue?

    The current revenue for Virogenbio is .

  • Who are Virogenbio’s investors?

    Espressif and Shenzhen Jinhengfu Private Equity Investment Fund Management have invested in Virogenbio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process